Immunotherapy

Immune system modulators are a range of immunotherapy drugs that suppress or stimulate your immune system. Certain types are targeted for specific areas or cancers, while others affect your broader immune system response.

Immune checkpoint inhibitors use specialized drugs to unleash stronger responses from your immune system. These checkpoints help keep the immune system from overreacting. However, increasing the immune system's reaction strength can be beneficial in some cases.

Chimeric Antigen Receptor T-Cells (CAR-T cells) are approved to treat some types of cancer, including Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Acute Lymphoblastic Leukemia and Multiple Myeloma. Novant Health Cancer Institute participates in studies using this type of treatment and others to target multiple types of cancers, giving you access to the latest treatments available.

Cancer treatment vaccines help stimulate your immune system and combat cancerous cells. These vaccines train your immune system to identify specific markers unique to cancer cells that aren't present in healthy cells. This helps your body more effectively locate and kill cancerous cells naturally.

Monoclonal antibodies are immune system proteins artificially created to target and kill cancerous cells in your body. The proteins are highly specialized for different cancers and can attach to and designate cancer cells, helping to direct your immune system response.